Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria-Reference-Cited by-同舟云学术

Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria

Published:2019-12 Issue:6 Volume:213 Page:1232-1239
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Vernuccio Federica¹²³⁴,Godfrey Devon⁵⁶,Meyer Mathias¹,Williamson Hannah V.⁷,Salama Joseph K.⁵⁶,Niedzwiecki Donna⁷,Stephens Sarah Jo⁵,Ronald James¹,Palta Manisha⁵⁶,Marin Daniele¹

Affiliation:

1. Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710.

2. Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University Hospital of Palermo, Palermo, Italy.

3. University Paris Diderot, Sorbonne Paris Cité, Paris, France.

4. Istituti di Ricovero e Cura a Carattere Scientifico, Centro Neurolesi Bonino Pulejo, Messina, Italy.

5. Department of Radiation Oncology, Duke University Medical Center, Durham, NC.

6. Radiation Oncology Service, Durham VA Medical Center, Durham, NC.

7. Duke Cancer Institute-Biostatistics, Duke University Medical Center, Durham, NC.

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.18.20842

Reference24 articles.

1. Radiation oncology in the era of precision medicine

2. Stereotactic body radiotherapy: A critical review for nonradiation oncologists

3. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma

4. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

5. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic resonance-guided focused ultrasound versus percutaneous thermal ablation in local control of bone oligometastases: a systematic review and meta-analysis;La radiologia medica;2024-02-02

2. Radiomics and liver: Where we are and where we are headed?;European Journal of Radiology;2024-02

3. Imaging Recommendations for Diagnosis, Staging and Management of Treatment-Related Complications in Cancer;Indian Journal of Medical and Paediatric Oncology;2023-03-01

4. Early complete tumor response as a survival predictor in hepatocellular carcinoma patients receiving stereotactic body radiation therapy;Clinical and Translational Radiation Oncology;2023-03

5. Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review;American Journal of Roentgenology;2022-10